Main text Patients with cancer are at high risk for severe clinical courses of COVID-19 and delays of antineoplastic treatment due to SARS-CoV-2 infections (). SARS-CoV-2 vaccinations were shown to be quite effective and well tolerated according to post-authorization data and real-life studies of hemato-oncological cohorts (). However, we ( Mair et al., 2022a Mair M.J. Berger J.M. Berghoff A.S. Starzer A.M. Ortmayr G. Puhr H.C. Steindl A. Perkmann T. Haslacher H. Strassl R. et al.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Manfred
Contact Manfred, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack